Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Adv Healthc Mater. 2018 Dec 13;8(2):e1801188. doi: 10.1002/adhm.201801188

Figure 2.

Figure 2.

Activation particle characterization. (a) Scanning electron microscope (SEM) images of red blood cell, microsphere, and HeLa silica microparticles. (b) Fluorescent and brightfield microscope images of activation particles at 20× magnification. (c) Biotin loading on activation particles quantified by FITC-neutravidin and flow cytometry. (d) Ratiometric loading of anti-CD3ε and anti-CD28 antibodies with fluorescently labeled neutravidin and flow cytometry.